NCT07241065 2025-11-21
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
AstraZeneca
Phase 1 Not yet recruiting
AstraZeneca
Princess Maxima Center for Pediatric Oncology